MoneyWorks4Me

Procter & Gamble Health informs about resignation of executive director cum CFO

17 Mar 2023 Evaluate

In accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Procter & Gamble Health has informed that Amit Gupta has tendered his resignation as Executive Director and Chief Financial Officer (CFO) of the Company effective close of business hours of March 31, 2023. Amit Gupta will be moving to a regional role within the Procter & Gamble Group.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..